These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8146568)

  • 41. Hormone replacement therapy: controversies, pros and cons.
    Warren MP; Halpert S
    Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):317-32. PubMed ID: 15261840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Report from the Argentinian Association for Health Research and Development (ACINDES). Socioeconomic analysis of hormone replacement therapy: impact of consumer satisfaction on the outcomes of therapy.
    Int J Technol Assess Health Care; 1994; 10(4):710-1. PubMed ID: 7843891
    [No Abstract]   [Full Text] [Related]  

  • 43. [Considerations on the cost-benefit analysis and health-related effectiveness of estrogen therapy during menopause].
    Schneider HP
    Med Welt; 1980 May; 31(22):828-33. PubMed ID: 6771485
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effect of hormonal drugs used during menopause on the cardiovascular system].
    Szymasiuk J; Sternadel Z; Bińkowska M
    Pol Tyg Lek; 1989 Dec 2-24; 44(49-52):970-2. PubMed ID: 2490303
    [No Abstract]   [Full Text] [Related]  

  • 45. Hormone replacement therapy in a risk-benefit perspective.
    Daly E; Vessey MP; Barlow D; Gray A; McPherson K; Roche M
    Maturitas; 1996 Mar; 23(2):247-59. PubMed ID: 8735363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Principles and overview of hormonal treatment of menopause].
    Rozenbaum H
    Soins Gynecol Obstet Pueric Pediatr; 1994 Feb; (153):7-11. PubMed ID: 8009392
    [No Abstract]   [Full Text] [Related]  

  • 47. Cost-effectiveness of hormone replacement therapy after the menopause.
    Tosteson AN; Weinstein MC
    Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):943-59. PubMed ID: 1822828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of hormone replacement.
    Weinstein MC; Tosteson AN
    Ann N Y Acad Sci; 1990; 592():162-72; discussion 185-92. PubMed ID: 2115756
    [No Abstract]   [Full Text] [Related]  

  • 49. Hormone replacement for osteoporosis.
    Griffin J; Robinson R
    Lancet; 1990 May; 335(8698):1163. PubMed ID: 1971896
    [No Abstract]   [Full Text] [Related]  

  • 50. When should postmenopausal women start taking oestrogen replacement therapy?
    Prince RL; Geelhoed EA
    Med J Aust; 1995 Feb; 162(4):173-4. PubMed ID: 7877535
    [No Abstract]   [Full Text] [Related]  

  • 51. Prescribing hormone replacement therapy.
    Kerrigan P
    Practitioner; 1989 Jan; 233(1461):11. PubMed ID: 2798280
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of the action of a new non-steroidal estrogen (Zeranolo-Ralone)].
    Menchini Fabris GF; Bianchi B
    Minerva Ginecol; 1977 Mar; 29(3):225-32. PubMed ID: 865724
    [No Abstract]   [Full Text] [Related]  

  • 53. Dependence and oestrogen replacement.
    Bewley S; Bewley T
    Lancet; 1992 Mar; 339(8796):814-5. PubMed ID: 1347843
    [No Abstract]   [Full Text] [Related]  

  • 54. Cost-effectiveness modelling.
    Barlow DH
    Hum Reprod; 2001 Dec; 16(12):2479-80. PubMed ID: 11726561
    [No Abstract]   [Full Text] [Related]  

  • 55. [Present state of hormonal therapy of menopause pathologies (the 10th Conference of CMAS CLS JEP and SOM CGPS CLS JEP, October 16 to 18, 2009)].
    Donát J
    Cas Lek Cesk; 2009; 148(12):659-61. PubMed ID: 20662397
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hormonal aspects of burning tongue--case report].
    Mravak M
    Acta Stomatol Croat; 1984; 18(3):223-6. PubMed ID: 6598288
    [No Abstract]   [Full Text] [Related]  

  • 57. One on one. Can I take hormone therapy for menopause if I have endometriosis?
    Mayo Clin Womens Healthsource; 2001 Dec; 5(12):8. PubMed ID: 14639203
    [No Abstract]   [Full Text] [Related]  

  • 58. [Socioeconomic stakes of menopause: evaluation of the cost-effectiveness studies].
    Plu-Bureau G; Bureau D; Thalabard JC
    Rev Prat; 1993 Dec; 43(20):2665-9. PubMed ID: 8146568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The cost-effectiveness of hormonal replacement therapy].
    Ylikorkala O
    Duodecim; 1996; 112(12):1039-40. PubMed ID: 10593003
    [No Abstract]   [Full Text] [Related]  

  • 60. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.